Showing results (1851-1860 of 3,159) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|May 9, 2017
BAP1 mutations in high-grade meningioma: implications for patient careGanesh M Shankar, Sandro Santagata
Neuro-Oncology|April 29, 2017
Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survivalTal Shahar, Uri Rozovski, Kenneth R Hess, et al.
Neuro-Oncology|April 29, 2017
Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor DatabaseLouis-Marie Terrier, Luc Bauchet, Valérie Rigau, et al.
Neuro-Oncology|April 29, 2017
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825Haley Gittleman, Daniel Lim, Michael W Kattan, et al.
Neuro-Oncology|April 29, 2017
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patientsJavier M Figueroa, Johan Skog, Johnny Akers, et al.
Neuro-Oncology|April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committeeKatherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Neuro-Oncology|September 4, 2016
The complex role of transglutaminase 2 in glioblastoma proliferationSoner Gundemir, Alina Monteagudo, Abdullah Akbar, et al.
Neuro-Oncology|August 31, 2016
Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomideMichael Wahl, Joanna J Phillips, Annette M Molinaro, et al.
Neuro-Oncology|September 2, 2016
Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trialsBenjamin M Ellingson, Robert J Harris, Davis C Woodworth, et al.
Neuro-Oncology|September 25, 2016
Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatmentJayson Hardcastle, Lisa Mills, Courtney S Malo, et al.
Pageof 316